Oncogenic miR-1825 promotes head and neck carcinogenesis via targeting FREM1.

Capik, Ozel; Gundogdu, Betul; Tatar, Arzu; Sahin, Abdulkadir; Chen, Fengju; Creighton, Chad J; Karatas, Omer Faruk

Capik, Ozel; Gundogdu, Betul; Tatar, Arzu; Sahin, Abdulkadir; Chen, Fengju; Creighton, Chad J; Karatas, Omer Faruk.

Afiliação

Capik O; Molecular Biology and Genetics Department, Erzurum Technical University, Erzurum, Turkey.
Gundogdu B; Molecular Cancer Biology Laboratory, High Technology Application and Research Center, Erzurum Technical University, Erzurum, Turkey.
Tatar A; Department of Medical Pathology, Faculty of Medicine, Ataturk University, Erzurum, Turkey.
Sahin A; Department of Otorhinolaryngology Diseases, Faculty of Medicine, Ataturk University, Erzurum, Turkey.
Chen F; Department of Otorhinolaryngology Diseases, Faculty of Medicine, Ataturk University, Erzurum, Turkey.
Creighton CJ; Department of Medicine and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
Karatas OF; Department of Medicine and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA.

J Cell Biochem ; 124(10): 1628-1645, 2023 Oct.

Article em En | MEDLINE | ID: mdl-37683055

Palavras-chave

head and neck squamous cell carcinoma; miR-1825; oncogene

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: J Cell Biochem Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Turquia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google